Split History
ETFs Holding ALKS »    ALKS Historical Stock Prices »
Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Alkermes is a biopharmaceutical company. Co. develops and commercialize in the U.S. products designed for patients suffering from addiction and schizophrenia. Co.'s key marketed products include: ARISTADA is an extended-release injectable suspension for the treatment of schizophrenia; VIVITROL is for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence; and AMPYRA/FAMPYRA is a treatment to improve walking in adults with multiple sclerosis who have walking disability. Co.'s product candidate include: ALKS 5461 for the treatment of Major Depressive Disorder; and ALKS 3831 is for the treatment of schizophrenia, among others. According to our ALKS split history records, Alkermes has had 1 split.
ALKS split history picture
Alkermes (ALKS) has 1 split in our ALKS split history database. The split for ALKS took place on May 15, 2000. This was a 2 for 1 split, meaning for each share of ALKS owned pre-split, the shareholder now owned 2 shares. For example, a 1000 share position pre-split, became a 2000 share position following the split.

When a company such as Alkermes splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. Looking at the ALKS split history from start to finish, an original position size of 1000 shares would have turned into 2000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alkermes shares, starting with a $10,000 purchase of ALKS, presented on a split-history-adjusted basis factoring in the complete ALKS split history. ALKS split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 03/26/2007
End date: 03/24/2017
Start price/share: $15.39
End price/share: $58.88
Dividends collected/share: $0.00
Total return: 282.59%
Average Annual Total Return: 14.36%
Starting investment: $10,000.00
Ending investment: $38,273.76
Years: 10.00
Date Ratio
05/15/20002 for 1
ALKS is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ALR Split History
ALXA Split History
ALXN Split History
AMDA Split History
AMED Split History
AMGN Split History
AMN Split History
AMPE Split History
AMRI Split History
AMRN Split History

HEICO Corporation (HEI)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Rosetta Genomics Ltd. (ROSG)
Condor Hospitality Trust, Inc. (CDOR)
Fibrocell Science, Inc. (FCSC)
VelocityShares Daily 2x VIX Medium Term ETN (TVIZ)
VelocityShares Daily 2x VIX Short Term ETN (TVIX)
VelocityShares VIX Short Term ETN (VIIX)
VelocityShares 3x Inverse Natural Gas ETN (DGAZ)
Wheeler Real Estate Investment Trust, Inc. (WHLR)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

ALKS Insider Buying

ALKS Split History | www.SplitHistory.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.